XML 68 R44.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation, Stock Option Activity (Details) - USD ($)
3 Months Ended 12 Months Ended
Feb. 25, 2025
Dec. 30, 2022
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Jun. 30, 2023
Dec. 31, 2024
Dec. 31, 2023
Unamortized Stock Compensation Expense [Abstract]                    
Shares issued for consulting services (in shares)   378,787                
Weighted-average grant date fair value, granted (in dollars per share)                 $ 4.7 $ 9.59
Common Stock [Member]                    
Number of Shares [Roll Forward]                    
Exercised (in shares)     (59,465) (40,535)   (156,073) (80,526) (1,409)    
Unamortized Stock Compensation Expense [Abstract]                    
Shares issued for consulting services (in shares) 100,000       100,000   100,000 100,000 100,000 200,000
Stock Options [Member]                    
Number of Shares [Roll Forward]                    
Options outstanding, beginning balance (in shares)           5,029,345     5,029,345  
Granted (in shares)                 1,199,648  
Exercised (in shares)                 (256,073)  
Forfeited (in shares)                 (599,857)  
Expired (in shares)                 0  
Options outstanding, ending balance (in shares)     5,373,063       5,029,345   5,373,063 5,029,345
Vested and expected to vest (in shares)     5,373,063           5,373,063  
Exercisable (in shares)     3,296,498           3,296,498  
Weighted Average Exercise Price [Roll Forward]                    
Options outstanding, beginning balance (in dollars per share)           $ 6.43     $ 6.43  
Granted (in dollars per share)                 5.11  
Exercised (in dollars per share)                 3.02  
Forfeited (in dollars per share)                 8.4  
Expired (in dollars per share)                 0  
Options outstanding, ending balance (in dollars per share)     $ 6.08       $ 6.43   6.08 $ 6.43
Vested and expected to vest (in dollars per share)     6.08           6.08  
Exercisable (in dollars per share)     $ 5.88           $ 5.88  
Weighted Average Remaining Contractual Life and Aggregate Intrinsic Value [Abstract]                    
Options outstanding, weighted average remaining contractual life                 7 years 1 month 9 days 7 years 5 months 1 day
Granted, weighted average remaining contractual life                 9 years 2 months 12 days  
Vested and expected to vest, weighted average contractual life                 7 years 1 month 9 days  
Exercisable, weighted average contractual life                 6 years 1 month 20 days  
Options outstanding, aggregate intrinsic value, beginning balance           $ 4,395,227     $ 4,395,227  
Granted, aggregate intrinsic value                 0  
Exercised, aggregate intrinsic value                 0  
Forfeited, aggregate intrinsic value                 0  
Expired, aggregate intrinsic value                 0  
Options outstanding, aggregate intrinsic value, ending balance     $ 50,439       $ 4,395,227   50,439 $ 4,395,227
Vested and expected to vest, aggregate intrinsic value     50,439           50,439  
Exercisable, aggregate intrinsic value     50,439           50,439  
Unamortized Stock Compensation Expense [Abstract]                    
Unamortized stock-based compensation expense     $ 10,633,050           $ 10,633,050  
Period for recognition                 2 years 6 months 14 days  
Weighted-average grant date fair value, granted (in dollars per share)                 $ 4.7